CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway
October 24, 2018 08:03 ET
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
UPDATE: Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board (IGAB)
October 01, 2018 08:12 ET
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board
September 28, 2018 07:40 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board
September 26, 2018 13:09 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board
September 21, 2018 08:23 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards
September 12, 2018 08:13 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Crown Baus Launches iCannabinoid Marketplace for Cannabis Science; Live Negotiating Platform to Revolutionize How the Medical Cannabis Industry Buys and Sells Equipment and Supplies
September 07, 2018 12:46 ET
|
Crown Baus Capital Corp.
Beverly Hills, CA, Sept. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate with investments primarily in five...
Cannabis Science Invited to Deliver Keynote Address at European Summit Organized by The University of Heidelberg and Harvard Medical School’s Global Health Catalyst
August 31, 2018 12:35 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
CANNABIS SCIENCE TODAY LAUNCHES ITS NEW CORPORATE WEBSITE
August 21, 2018 07:48 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the...
Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements
August 13, 2018 11:53 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce it is in...